Cyfuse Biomedical K.K. (TYO:4892)
Japan · Delayed Price · Currency is JPY 610.00
+5.00 (0.83%)
At close: Mar 27, 2026
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 6.08 billion as of March 27, 2026. Its market cap has decreased by -40.21% in one year.
Market Cap
6.08B
Enterprise Value
3.66B
Revenue
230.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
610.00
Market Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 6.08B, a decrease of -53.26%. That is a compound annual growth rate of -20.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.08B | 7.18% |
| Dec 30, 2025 | 5.67B | 54.23% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
| Dec 1, 2022 | 13.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 20.70B |
| Pharma Foods International | 20.42B |
| Taiko Pharmaceutical | 15.18B |
| Wakamoto Pharmaceutical | 12.49B |
| Morishita Jintan | 9.55B |
| Solasia Pharma K.K. | 8.89B |
| SymBio Pharmaceuticals | 7.61B |
| MedRx | 6.95B |